Article Details

Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for ...

Retrieved on: 2023-10-15 23:45:48

Tags for this article:

Click the tags to see associated articles and topics

Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for .... View article details on hiswai: https://www.prnewswire.com/news-releases/everest-medicines-licensing-partner-pfizer-announces-us-fda-approves-etrasimod-for-adults-with-moderately-to-severely-active-ulcerative-colitis-301956907.html

Excerpt

PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) has received approval from the ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up